Application of salvianolic acid B salt in preparing medicament for inhibiting hepatic stellate cell migration

A technology of hepatic stellate cells and salvianolic acid, which is applied in the application field of medicine, and can solve the problems such as no relevant reports of salvianolic acid B salt

Inactive Publication Date: 2013-03-27
SHUGUANG HOSPITAL AFFILIATED WITH SHANGHAI UNIV OF T C M
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no relevant report on the role of salvianolic acid B salt in inhibiting the migration of hepatic stellate cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of salvianolic acid B salt in preparing medicament for inhibiting hepatic stellate cell migration
  • Application of salvianolic acid B salt in preparing medicament for inhibiting hepatic stellate cell migration
  • Application of salvianolic acid B salt in preparing medicament for inhibiting hepatic stellate cell migration

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] The salvianolic acid B salt of the present invention is made into tablets according to methods known to those skilled in the art. Salvianolic acid B salt tablets, each containing 100mg of salvianolic acid B salt, 100mg of microcrystalline cellulose, 40mg of micropowder silica gel, 20mg of lactose, and 1.0mg of magnesium stearate. Usage: 1 tablet each time, 2-3 times a day, 5-6 days a week, every 3-4 weeks as a course of treatment.

Embodiment 2

[0068] Salvianolic acid B salt of the present invention is made into capsules according to methods known to those skilled in the art. Salvianolic acid B salt capsules, each containing 100mg of salvianolic acid B salt. Usage: 1 capsule each time, 2-3 times a day, 5-6 days a week, every 3-4 weeks as a course of treatment.

Embodiment 3

[0070] Salvianolic acid B salt of the present invention is prepared into granules according to methods known to those skilled in the art. Salvianolic acid B salt granules, each bag contains 100mg of salvianolic acid B salt, 100mg of microcrystalline cellulose, 40mg of micropowder silica gel, 1.0mg of stearic acid, and 20mg of lactose. Usage: 1 bag each time, 2-3 times a day, 5-6 days a week, every 3-4 weeks as a course of treatment.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses application of salvianolic acid B salt in preparing a medicament for inhibiting hepatic stellate cell migration. A screening platform of PDGF (platelet derived growth factor) induced human hepatic stellate cell strain (LX-2) migration is designed, and the fact that the salvianolic acid B salts with the concentrations of 10<-4> and 10<-7>mol/L both can be used for inhibiting migration of a PDGF induced hepatic stellate cell (HSC) is discovered.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, and in particular relates to the application of salvianolic acid B salt in the preparation of medicines for inhibiting the migration of hepatic stellate cells. Background technique [0002] Salvianolic acid B salt, also known as salvianolic acid B or shikonic acid B, is extracted from the natural plant Salvia miltiorrhiza. Lowering blood pressure, lowering blood sugar, anti-inflammatory, anti-allergic, anti-oxidation, anti-infection, used to treat cervical erosion, skin diseases and acne, etc. It has important pharmacological effects on the heart, brain, liver and other organs. [0003] Various liver diseases, such as chronic hepatitis B, chronic hepatitis C, alcoholic or non-alcoholic fatty liver disease, autoimmune liver disease, drug-induced liver disease, chronic schistosomiasis, and some metabolic or congenital chronic liver diseases can be passed Liver fibrosis progresses to c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/343A61P1/16
Inventor 徐列明张展
Owner SHUGUANG HOSPITAL AFFILIATED WITH SHANGHAI UNIV OF T C M
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap